ELICIO THERAPEUTICS INC Share Price Today: Live Updates & Key Insights

ELICIO THERAPEUTICS INC share price today is $10.83, up -9.43%. The stock opened at $11.8 against the previous close of $11.98, with an intraday high of $11.845 and low of $10.725.

ELICIO THERAPEUTICS INC Share Price Chart

ELICIO THERAPEUTICS INC

us-stock
To Invest in {{usstockname}}
us-stock

ELICIO THERAPEUTICS INC Share Price Performance

$10.83 -0.0943(-9.43%) ELTX at 23 Mar 2026 12:52 PM Biotechnology
Lowest Today 10.725
Highest Today 11.845
Today’s Open 11.8
Prev. Close 11.98
52 Week High 14.93
52 Week Low 4.60
Day’s Range: Low 10.725 High 11.845
52-Week Range: Low 4.60 High 14.93
1 day return -
1 Week return -10.24
1 month return +17.4
3 month return +35.75
6 month return -2.51
1 year return +27.76
3 year return +97.49
5 year return -93.78
10 year return -

ELICIO THERAPEUTICS INC Institutional Holdings

ELICIO THERAPEUTICS INC Market Status

Strong Buy: 1

Buy: 1

Hold: 0

Sell: 0

Strong Sell: 0

ELICIO THERAPEUTICS INC Fundamentals

Market Cap 199.60 M

PB Ratio 122.0033

PE Ratio 0.0

Enterprise Value 195.55 M

Total Assets 25.86 M

Volume 198790

ELICIO THERAPEUTICS INC Company Financials

Annual Revenue FY23:0 0.0M, FY22:0 0.0M, FY21:0 0.0M, FY20:0 0.0M, FY19:0 0.0M

Annual Profit FY23:null 0.0M, FY22:null 0.0M, FY21:null 0.0M, FY20:null 0.0M, FY19:null 0.0M

Annual Net worth FY23:-32896688 -32.9M, FY22:-28207688 -28.2M, FY21:-26400698 -26.4M, FY20:-15712142 -15.7M, FY19:-12260866 -12.3M

Quarterly Revenue Q3/2025:0 0.0M, Q2/2025:0 0.0M, Q1/2025:0 0.0M, Q3/2024:0 0.0M, Q2/2024:0 0.0M

Quarterly Profit Q3/2025:-283000 -0.3M, Q2/2025:-281000 -0.3M, Q1/2025:-278000 -0.3M, Q3/2024:null 0.0M, Q2/2024:-293000 -0.3M

Quarterly Net worth Q3/2025:-10083000 -10.1M, Q2/2025:-10561000 -10.6M, Q1/2025:-11209000 -11.2M, Q3/2024:-18838000 -18.8M, Q2/2024:-7229000 -7.2M

About ELICIO THERAPEUTICS INC & investment objective

Company Information Elicio Therapeutics, Inc., a clinical-stage biotechnology company, develops immunotherapies for the treatment of cancer. Its lead product candidate, ELI-002, is a multivalent lymph node-targeted amphiphile (AMP) peptide vaccine that is in Phase II clinical trials for seven Kirsten rat sarcoma viral oncogene homolog driver mutations. The company also develops ELI-007, a multivalent lymph node-targeted AMP peptide treatment for mutant b-raf murine sarcoma viral oncogene homolog B1-(BRAF) driven cancers, and ELI-008, a multivalent lymph node-targeted AMP peptide vaccine in preclinical studies for the treatment of mutated tumor protein p53-expressing cancers. Elicio Therapeutics, Inc. is headquartered in Boston, Massachusetts.

Organisation Biotechnology

Employees 33

Industry Biotechnology

CEO Mr. Robert T. Connelly

Trading and brokerage services provided by

Technology Services provided by Motilal Oswal Financial Services:

Disclaimer: These services are not for exchange traded products. The securities quoted are exemplary and not recommendatory. Please be informed that US Stocks are not exchange traded funds in India and Motilal Oswal Financial Services acts in the capacity of facilitator of this product. All disputes with respect to the transaction facilitation services, would not have access to Indian Exchange investor redressal forum or Arbitration mechanism in India. T&C apply*

Take your next step

Talk to our investment advisor for stock recommendations
Left
Get expert assistance for portfolio management
Right

ELICIO THERAPEUTICS INC FAQs

What is the share price of ELICIO THERAPEUTICS INC today?

The current share price of ELICIO THERAPEUTICS INC is $10.83.

Can I buy ELICIO THERAPEUTICS INC shares in India?

Yes, Indian investors can buy ELICIO THERAPEUTICS INC shares by opening an international trading and demat account with Motilal Oswal.

How to buy ELICIO THERAPEUTICS INC shares in India?

You can easily invest in ELICIO THERAPEUTICS INC shares from India by:

Can I buy fractional shares of ELICIO THERAPEUTICS INC?

Yes, many platforms allow you to buy fractional shares starting from as low as $1.

What is the market capitalization value of ELICIO THERAPEUTICS INC?

ELICIO THERAPEUTICS INC has a market cap of $199.60 M.

In which sector does ELICIO THERAPEUTICS INC belong?

ELICIO THERAPEUTICS INC operates in the Biotechnology sector.

What documents are required to invest in ELICIO THERAPEUTICS INC stocks?

To invest, you typically need:

What is the PE and PB ratio of ELICIO THERAPEUTICS INC?

The PE ratio of ELICIO THERAPEUTICS INC is N/A and the PB ratio is 122.00.